DIABETIC MACULAR EDEMA: TREATMENT 2

Back

SAN GIOVANNI

December, 06th | 10:15 - 11:00
DIABETIC MACULAR EDEMA: TREATMENT 2

Add to calendar
0

Chairs: DO DIANA V., KOROBELNIK JEAN-FRANÇOIS, MIDENA EDOARDO, SADDA SRINIVAS
December, 06th | 10:15 - 10:19
Precision ophthalmology: tailoring DME treatment
MIDENA EDOARDO
Add to calendar
0
December, 06th | 10:19 - 10:23
Faricimab: Hard Exudates in Yosemite/Rhine Diabetic Macular Edema (DME) Clinical Trials
RACHITSKAYA ALEKSANDRA
Add to calendar
0
December, 06th | 10:23 - 10:27
Real-World effectiveness of Faricimab in patients: 12-Month outcomes from the FARETINA Study
LENG THEODORE
Add to calendar
0
December, 06th | 10:27 - 10:31
New benchmarks in the management of DME
LATTANZIO ROSANGELA
Add to calendar
0
December, 06th | 10:31 - 10:35
Outcomes With Aflibercept 8 mg and 2 mg for DME By Baseline BCVA 20/50 or Worse or 20/40 or Better in the PHOTON Trial
FERRONE PHILIP
Add to calendar
0
December, 06th | 10:35 - 10:39
IOP and Glaucoma-related Outcomes With Aflibercept 8 mg and 2 mg in Patients With DME Through Week 96 in PHOTON
KOROBELNIK JEAN-FRANÇOIS
Add to calendar
0
December, 06th | 10:39 - 10:43
Impact of residual fluid on visual outcomes in diabetic macular edema
SADDA SRINIVAS
Add to calendar
0
December, 06th | 10:43 - 10:47
Update on Aflibercept 8mg for Diabetic Macular Edema: The PHOTON Study
DO DIANA V.
Add to calendar
0
December, 06th | 10:47 - 11:00
Debate: durability, multitarget approach, or synergic effect of different treatments?
Add to calendar
0

General chair

Stanislao Rizzo

Organizing Secretariat

Logo AP Meetings

AP Meetings

Tel: +39 031 461938

secretariat@floretina.com